|Mr. Richard B. Hancock||Interim Pres, CEO & Director||80.08k||N/A||1959|
|Mr. Daniel R. Hart||Chief Financial Officer||477.95k||N/A||1973|
|Mr. Mark R. Ziebell||VP, Gen. Counsel & Corp. Sec.||485.05k||N/A||1964|
|Mr. Richard Richieri||Chief Operations Officer||N/A||N/A||1965|
|Ms. Lorna Larson||Sr. Director of HR||N/A||N/A||N/A|
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and Current Good Manufacturing Practices (CGMP) commercial manufacturing services focused on biopharmaceutical products derived from mammalian cell culture for biotechnology and pharmaceutical companies. The company produces monoclonal antibodies and recombinant proteins in batch, fed-batch, and perfusion modes; and offers services, including cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing, and regulatory submission and support. It also provides various process development services, such as cell line development and optimization, cell culture and feed optimization, analytical methods development, and product characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.
Avid Bioservices, Inc.’s ISS Governance QualityScore as of October 4, 2019 is 4. The pillar scores are Audit: 2; Board: 6; Shareholder Rights: 4; Compensation: 5.